Gilliland Jeter Wealth Management LLC Invests $269,000 in Encompass Health Co. (NYSE:EHC)

Gilliland Jeter Wealth Management LLC purchased a new position in shares of Encompass Health Co. (NYSE:EHC) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 4,035 shares of the company’s stock, valued at approximately $269,000.

Several other large investors also recently modified their holdings of EHC. McGlone Suttner Wealth Management Inc. bought a new position in Encompass Health in the 4th quarter worth approximately $30,000. GAMMA Investing LLC bought a new position in Encompass Health in the 4th quarter worth approximately $33,000. C M Bidwell & Associates Ltd. bought a new position in Encompass Health in the 3rd quarter worth approximately $35,000. Headlands Technologies LLC bought a new position in Encompass Health in the 4th quarter worth approximately $70,000. Finally, Harvest Fund Management Co. Ltd bought a new position in Encompass Health in the 3rd quarter worth approximately $109,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

EHC has been the subject of several analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $83.00 price objective on shares of Encompass Health in a report on Friday, February 9th. Mizuho raised their price target on shares of Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a report on Thursday. Barclays raised their price target on shares of Encompass Health from $101.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday. Raymond James reissued a “strong-buy” rating and issued a $95.00 price target (up from $85.00) on shares of Encompass Health in a report on Friday. Finally, Stephens reissued an “overweight” rating and issued a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $86.56.

Encompass Health Price Performance

Shares of NYSE EHC traded down $0.26 during mid-day trading on Friday, reaching $82.47. 706,619 shares of the company were exchanged, compared to its average volume of 756,857. The stock has a market capitalization of $8.26 billion, a PE ratio of 22.29, a PEG ratio of 1.50 and a beta of 0.94. The company’s 50 day moving average price is $78.25 and its 200 day moving average price is $70.87. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $85.84. The company has a quick ratio of 1.28, a current ratio of 1.37 and a debt-to-equity ratio of 1.14.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $0.93 by $0.19. The company had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The firm’s revenue was up 13.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.88 EPS. Sell-side analysts forecast that Encompass Health Co. will post 4.04 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.73%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s payout ratio is presently 16.22%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.